[
  {
    "ts": "2026-02-28T12:11:56+00:00",
    "headline": "Why West Pharmaceutical (WST) Is Up 5.5% After New US$1 Billion Buyback And Dividend Increase",
    "summary": "In February 2026, West Pharmaceutical Services’ Board authorized a new share repurchase program of up to US$1.00 billion with no expiration date and declared a regular quarterly dividend of US$0.22 per share, payable on May 6, 2026 to shareholders of record on April 29, 2026. This renewed commitment to buybacks and dividends, following full use of the prior repurchase program, highlights how management is currently prioritizing returning excess cash to shareholders. With this sizable new...",
    "url": "https://finance.yahoo.com/news/why-west-pharmaceutical-wst-5-121156908.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "3130e0a4-6011-3f8f-9ba7-a35c08ae2929",
      "content": {
        "id": "3130e0a4-6011-3f8f-9ba7-a35c08ae2929",
        "contentType": "STORY",
        "title": "Why West Pharmaceutical (WST) Is Up 5.5% After New US$1 Billion Buyback And Dividend Increase",
        "description": "",
        "summary": "In February 2026, West Pharmaceutical Services’ Board authorized a new share repurchase program of up to US$1.00 billion with no expiration date and declared a regular quarterly dividend of US$0.22 per share, payable on May 6, 2026 to shareholders of record on April 29, 2026. This renewed commitment to buybacks and dividends, following full use of the prior repurchase program, highlights how management is currently prioritizing returning excess cash to shareholders. With this sizable new...",
        "pubDate": "2026-02-28T12:11:56Z",
        "displayTime": "2026-02-28T12:11:56Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/06bbda48bd77be658a8c5765fd6bc2ab",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4G9ppBeYPHN150Vf7ljszA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/06bbda48bd77be658a8c5765fd6bc2ab.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rJ2VkF_7pHDs8.rNQqRscw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/06bbda48bd77be658a8c5765fd6bc2ab.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/why-west-pharmaceutical-wst-5-121156908.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-west-pharmaceutical-wst-5-121156908.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "WST"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]